Pitfalls in cytokine analysis in inflammatory bowel disease

C Fiocchi1, K Fukushima, S A Strong

  • 1Division of Gastroenterology, Case Western Reserve University School of Medicine (BRB), Cleveland, OH 44106-4952, USA.

Insights

Analyzing cytokine production in inflammatory bowel disease (IBD) requires careful consideration of patient and sample variables. Addressing these pitfalls will clarify the role of cytokines in Crohn

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Cytokine analysis is crucial for understanding Crohn's disease and ulcerative colitis.
  • Numerous studies have generated extensive data on cytokine production in IBD.
  • Interpretation of this data is often hindered by methodological and patient-related factors.

Purpose of the Study:

  • To highlight critical patient- and sample-related factors that influence cytokine analysis in IBD.
  • To emphasize the need for standardized approaches in cytokine research for IBD.
  • To facilitate a clearer understanding of cytokine roles in IBD pathogenesis.

Main Methods:

  • Review of existing literature on cytokine analysis in inflammatory bowel disease.
  • Identification and categorization of common pitfalls in sample collection, processing, and analysis.
  • Discussion of the impact of clinical parameters, sample types, and detection techniques.

Main Results:

  • Key variables affecting cytokine analysis include clinical parameters, circulating vs. intestinal levels, tissue selection, cellular sources, inducer effects, and detection methods.
  • Lack of attention to these variables complicates the interpretation of cytokine data in IBD.
  • Standardization across these factors is essential for reliable results.

Conclusions:

  • A comprehensive understanding of cytokine roles in IBD pathogenesis requires careful consideration of all identified variables.
  • Addressing these analytical pitfalls will improve the reliability and interpretability of cytokine data in IBD research.
  • Standardized cytokine analysis protocols are needed to advance IBD research and patient care.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...